semaglutide methylcobalamin compound Vitamin B12 Compound Semaglutide
Description
Making the switch from semaglutide to tirzepatide
My introduction to semaglutide wasnt a headline or a hype thread
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
With GLP-1 adoption accelerating, size is changing, but so is identity
